Our review of the inspection and your firm’s websites (www.getb-gger.com and www.drjoelkaplan.com) determined that the MegaVac System is adulterated under section 501(f)(1)(B) of the Act, 21 U.S.C. § 351(f)(1)(B), because your firm does not have an approved application for premarket approval (PMA) in effect pursuant to section 515(a) of the Act, 21 U.S.C. § 360e(a), or an approved application for an investigational device exemption (IDE) under section 520(g) of the Act, 21 U.S.C. § 360j(g) for the device as described and marketed. The device is also misbranded under section 502(o) the Act, 21 U.S.C. § 352(o), because your firm introduced or delivered for introduction into interstate commerce for commercial distribution this device with major changes or modifications to the intended use without submitting a new premarket notification to FDA as required by section 510(k) of the Act, 21 U.S.C. § 360(k), and 21 CFR 807.81(a)(3)(ii).This letter gets only gets better (if not MUCH more textually NSFW), but I'm afraid I'm going to
Honestly, I did not intend for this feature to become a "naughty medical device of the week" thing, but, um, I cannot resist.
I feel a strange sense of satisfaction seeing a warning letter to medical device purveyors of that particular genre.
ReplyDeleteLove these warning letters. Get a hoot out of them every time.